On January 4, 2022 Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), reported that Dr. Henry Ji, Chairman and CEO, will participate in the following upcoming panel at the Longwood Healthcare Leaders Winter Conference (Press release, Sorrento Therapeutics, JAN 4, 2022, View Source [SID1234598097]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
January 6th at 11:50 am PT / 2:50 pm ET
HOW M&A SPURS INNOVATION
Mark Enyedy, CEO, ImmunoGen; Henry Ji, CEO, Sorrento Therapeutics; Rachna Khosla, SVP, BD, Amgen; Stuart Mackey, Global Head, BD, Daiichi Sankyo
Moderator: Chad Shear, Principal, Fish & Richardson
Conference information: January 6-7, 2022 Webconference | Longwood Healthcare Leaders
Longwood Healthcare Leaders meetings are invitation-only forums typically held at leading academic institutions. Biopharma CEOs, heads of R&D, academic researchers, and healthcare investors join off-the-record discussions that generate new company ideas and approaches for Longwood Fund and members of our biopharma ecosystem, creating strategic business opportunities to advance the industry and bring important medicines to patients